Abbott Laboratories will report earnings pre-market on January 22, with an earnings consensus of $1.04 per share. See why I ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Abbott Laboratories closed $8.24 below its 52-week high ($121.64), which the company achieved on March 8th.

We recently compiled a list of the 10 Best January Dividend Stocks To Buy. In this article, we are going to take a look at ...

In this article, we will take a look into Abbott Laboratories's (NYSE:ABT) DCF analysis, a reliable and data-driven approach ...

International Assets Investment Management LLC reduced its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 99.1% during the 4th quarter, Holdings Channel reports. The fund owned 14,721 shares ...

In a report released yesterday, Lee Hambright from Bernstein maintained a Buy rating on Abbott Laboratories (ABT – Research Report), with a ...

Bernstein analyst Lee Hambright lowered the firm’s price target on Abbott (ABT) to $135 from $138 and keeps an Outperform rating on the shares ...

North Chicago-based Abbott announced last month it reached a settlement agreement with Dexcom over all outstanding patent disputes relating to their glucose monitoring products, which estimate blood ...

Abbott Laboratories (ABT) stock saw a modest uptick, ending the day at $113.83 which represents a slight increase of $0.39 or 0.34% from the prior close of $113.44. The stock opened at $113.94 and ...

Abbott Laboratories (NYSE:ABT – Free Report) had its price objective boosted by Evercore ISI to $136.00 in a report released on Thursday morning,Stock Target Advisor reports. They currently have a buy ...

This month, we explore the 125-year-old history of Abbott Laboratories and its most significant milestone to date – the creation of its own independent company, AbbVie. In 1888, a 30-year-old ...